IHL
TEVA icon

Investment House LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Investment House LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,600
Closed -$103K – 189
2021
Q3 		$103K Hold
10,600
– – 0.01% 185
2021
Q2 		$104K Hold
10,600
– – 0.01% 194
2021
Q1 		$122K Sell
10,600
-8,800
-45% -$101K 0.01% 189
2020
Q4 		$187K Hold
19,400
– – 0.01% 216
2020
Q3 		$175K Hold
19,400
– – 0.01% 200
2020
Q2 		$239K Sell
19,400
-4,600
-19% -$52K 0.02% 173
2020
Q1 		$216K Hold
24,000
– – 0.02% 161
2019
Q4 		$235K Hold
24,000
– – 0.02% 202
2019
Q3 		$165K Sell
24,000
-2,800
-10% -$21.5K 0.02% 193
2019
Q2 		$247K Sell
26,800
-200
-0.7% -$2.41K 0.03% 176
2019
Q1 		$423K Sell
27,000
-1,600
-6% -$28.2K 0.05% 143
2018
Q4 		$441K Sell
28,600
-900
-3% -$18.5K 0.06% 134
2018
Q3 		$635K Hold
29,500
– – 0.07% 127
2018
Q2 		$717K Buy
29,500
+200
+0.7% +$4.08K 0.08% 121
2018
Q1 		$501K Hold
29,300
– – 0.06% 135
2017
Q4 		$555K Sell
29,300
-2,700
-8% -$40.6K 0.07% 133
2017
Q3 		$563K Sell
32,000
-41,090
-56% -$925K 0.07% 131
2017
Q2 		$2.43M Sell
73,090
-4,045
-5% -$125K 0.33% 77
2017
Q1 		$2.48M Sell
77,135
-3,475
-4% -$119K 0.35% 76
2016
Q4 		$2.92M Sell
80,610
-6,725
-8% -$269K 0.44% 71
2016
Q3 		$4.02M Sell
87,335
-3,700
-4% -$193K 0.6% 56
2016
Q2 		$4.57M Hold
91,035
– – 0.73% 52
2016
Q1 		$4.87M Buy
91,035
+200
+0.2% +$11.7K 0.78% 47
2015
Q4 		$5.96M Sell
90,835
-2,100
-2% -$130K 0.97% 38
2015
Q3 		$5.25M Hold
92,935
– – 0.91% 40
2015
Q2 		$5.49M Hold
92,935
– – 0.88% 38
2015
Q1 		$5.79M Sell
92,935
-75
-0.1% -$4.36K 0.93% 36
2014
Q4 		$5.35M Hold
93,010
– – 0.86% 40
2014
Q3 		$5M Hold
93,010
– – 0.83% 40
2014
Q2 		$4.88M Sell
93,010
-1,600
-2% -$81.8K 0.83% 40
2014
Q1 		$5M Hold
94,610
– – 0.89% 36
2013
Q4 		$3.79M Sell
94,610
-10,135
-10% -$399K 0.68% 51
2013
Q3 		$3.96M Hold
104,745
– – 0.8% 45
2013
Q2 		$4.11M Buy
+104,745
New +$4.08M 0.89% 44

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Investment House LLC's TEVA Position: Q4 2021 in Review

Investment House LLC sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 10,600 shares — an estimated $103K sold.

Investment House LLC first reported a position in TEVA in Q2 2013 and held it in 34 quarters. The position peaked at $5.96M in Q4 2015. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Investment House LLC reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Investment House LLC sold 10,600 Teva Pharmaceuticals shares in Q4 2021, an estimated $103K.
  • Investment House LLC first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 34 quarters.
  • Investment House LLC's Teva Pharmaceuticals position peaked at $5.96M in Q4 2015.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Investment House LLC's 13F filing for Q4 2021, filed 9 Feb 2022.